Global Neurology Academy
The Global Neurology Academy (GNA) Series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
1-15 of 57
Secondary Stroke Prevention in Focus: Addressing Residual Thrombotic Risk
CME/CE Broadcast ReplaySecondary Stroke Prevention in Focus: Addressing Residual Thrombotic Risk
Deborah Kerrigan, MD
Clay Johnston, MD
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
CME/CEReimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
CME/CEEngineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
CME/CE Broadcast ReplayWhen “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
Dani Cabral, MD
David Weisman, MD
Borderline Biomarkers: When a Blood Test Is Not Enough
MinuteCE®Borderline Biomarkers: When a Blood Test Is Not Enough
Dani Cabral, MD
David Weisman, MD
- advertisement
Dani Cabral, MD
David Weisman, MD
Stroke-Like Symptoms During Treatment: Safety First
MinuteCE®Stroke-Like Symptoms During Treatment: Safety First
Dani Cabral, MD
David Weisman, MD
Talking Through Benefits, Risks, and Patient Priorities
MinuteCE®Talking Through Benefits, Risks, and Patient Priorities
Dani Cabral, MD
David Weisman, MD
Dani Cabral, MD
David Weisman, MD
Dani Cabral, MD
David Weisman, MD
Antithrombotics and Amyloid Therapy: Balancing Risk
MinuteCE®Antithrombotics and Amyloid Therapy: Balancing Risk
Dani Cabral, MD
David Weisman, MD
- advertisement
Advancing Acromegaly Care: Diving Deeper Into Diagnosis, Guideline Application, and Emerging Therapies—A Fireside Chat With Expert Perspectives
CME/CE Broadcast ReplayAdvancing Acromegaly Care: Diving Deeper Into Diagnosis, Guideline Application, and Emerging Therapies—A Fireside Chat With Expert Perspectives
Maria Fleseriu, MD, FACE
Beverly MK Biller, MD, FACP
Mark Gurnell, MD
Transitioning to Adult Care in Rett Syndrome: Navigating Challenges
MinuteCE®Transitioning to Adult Care in Rett Syndrome: Navigating Challenges
Jennifer Martelle Tu, MD, PhD
Payal Kenia Gu, MD
Managing Rett Syndrome: Building a Multidisciplinary Care Approach
MinuteCE®Managing Rett Syndrome: Building a Multidisciplinary Care Approach
Payal Kenia Gu, MD
David Lieberman MD, PhD